Rare diseases
Investigational molecules
Locations
Back to France1 537 clinical trials in Toulon, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy
FranceStudy on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment
FranceStudy of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
FranceStudy of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer
FranceStudy of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer
FranceStudy Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
FranceStudy Comparing [177Lu]LU-PSMA-I&T and Hormone Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceStudy on the Effectiveness of High-Flow Oxygen Therapy for Migraine Attacks in Emergency Department Patients
FranceStudy on the Safety and Effectiveness of Pembrolizumab for Patients with Kidney Cancer After Surgery
FranceStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
FranceStudy on the Safety and Effectiveness of MK-5475 for Adults with Pulmonary Hypertension and COPD
FranceStudy of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer treatments, including innovative combination therapies and immunotherapy approaches. Multiple studies evaluating novel drug combinations to improve patient outcomes.
Research spans various disease stages and includes both early-stage and metastatic cancer treatments.
Studies investigating treatments for chronic lymphocytic leukemia and blood-related conditions. Research includes evaluation of novel drug combinations and targeted therapies.
Focus on improving treatment outcomes for previously untreated patients with coexisting conditions.
Investigations into stroke prevention and treatment of thrombotic conditions. Studies evaluating new anticoagulants and therapeutic approaches for various cardiovascular conditions.
Clinical trials examining innovative treatments for atrial fibrillation and deep vein thrombosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
